Compare $EGRX vs $ZEOX | Chartloom

Compare

$EGRX vs $ZEOX

Eagle Pharmaceuticals Inc · ZEO ScientifiX Inc

EGRX

Eagle Pharmaceuticals Inc

ZEOX

ZEO ScientifiX Inc

Compare $EGRX vs $ZEOX

Comparing Eagle Pharmaceuticals Inc and ZEO ScientifiX Inc

EGRXEagle Pharmaceuticals Inc

ZEOXZEO ScientifiX Inc

EGRXEagle Pharmaceuticals Inc

Market cap

$13M

P/E (TTM)

1.06x

Forward P/E (NTM)

0.25x

Forward P/S (NTM)

0.05x

Rev growth (TTM)

-5.4%

YTD performance

185.3%

52W performance

49.2%

FCF yield

-74.5%

ZEOXZEO ScientifiX Inc

Market cap

$9M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

52.8%

YTD performance

-55.7%

52W performance

-16.5%

FCF yield

-14.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EGRX

ZEOX

Detailed metrics comparison

EGRX

Eagle Pharmaceuticals Inc

ZEOX

ZEO ScientifiX Inc

Market Cap

EGRX$13M

ZEOX$9M

Enterprise Value

EGRX$67M

ZEOX$8M

Price

EGRX$0.97

ZEOX$1.19

P/E Ratio

EGRX1.06x

ZEOXN/A

P/S Ratio

EGRX0.05x

ZEOX1.33x

EV/Sales

EGRX0.26x

ZEOX1.11x

EV/EBITDA

EGRX1.07x

ZEOX0.00x

P/B Ratio

EGRX0.05x

ZEOX16.07x

P/FCF Ratio

EGRXN/A

ZEOXN/A

EV/FCF

EGRX-7.18x

ZEOX-5.77x

PEG Ratio

EGRXN/A

ZEOXN/A

Forward P/E (NTM)

EGRX0.25x

ZEOXN/A

Forward P/S (NTM)

EGRX0.05x

ZEOXN/A

Revenue (TTM)

EGRX$258M

ZEOX$7M

Revenue Growth (YoY)

EGRX-5.4%

ZEOX52.8%

Forward Rev Growth

EGRX0.0%

ZEOX0.0%

Gross Margin (TTM)

EGRX69.9%

ZEOX81.5%

Operating Margin (TTM)

EGRX14.0%

ZEOX0.0%

EBITDA Margin (TTM)

EGRX24.5%

ZEOX-58.0%

Net Margin (TTM)

EGRX4.7%

ZEOX-55.6%

FCF Margin (TTM)

EGRX-3.6%

ZEOX-19.3%

Net Income (TTM)

EGRX$12M

ZEOX$-4M

FCF (TTM)

EGRX$-9M

ZEOX$-1M

EPS (TTM)

EGRX$0.92

ZEOX-$0.50

ROE (TTM)

EGRX5.0%

ZEOX0.0%

ROA (TTM)

EGRX3.0%

ZEOX-16123.0%

ROIC (TTM)

EGRX3.9%

ZEOX0.0%

Cash

EGRX$15M

ZEOX$2M

Debt

EGRX$70M

ZEOX$343K

Net Cash/Debt

EGRX$-55M

ZEOX$2M

Current Ratio (TTM)

EGRX2.16x

ZEOX1.05x

Quick Ratio (TTM)

EGRX1.52x

ZEOX0.68x

Debt/Equity (TTM)

EGRX0.28x

ZEOX0.48x

Debt/Assets (TTM)

EGRX0.0%

ZEOX0.0%

Interest Coverage (TTM)

EGRXN/A

ZEOXN/A

Net Debt/EBITDA (TTM)

EGRX0.00x

ZEOX0.00x

Beta

EGRX0.88

ZEOX1.94

52W Performance

EGRX49.2%

ZEOX-16.5%

YTD Performance

EGRX185.3%

ZEOX-55.7%

% from 52W High

EGRX-74.9%

ZEOX-60.4%

% from 52W Low

EGRX88081.8%

ZEOX22.2%

Asset Turnover (TTM)

EGRX0.64x

ZEOX2.90x

FCF Yield (TTM)

EGRX-74.5%

ZEOX-14.5%

Earnings Yield (TTM)

EGRX96.0%

ZEOX-41.8%

Dividend Yield (TTM)

EGRXN/A

ZEOXN/A

Rule of 40

EGRX-9.0

ZEOX33.4

EV/GP/RG

EGRXN/A

ZEOXN/A

Ticker research

View EGRX research View ZEOX research

Metric	EGRX Eagle Pharmaceuticals Inc	ZEOX ZEO ScientifiX Inc
Market & Valuation
Market Cap	$13M	$9M
Enterprise Value	$67M	$8M
Price	$0.97	$1.19
P/E Ratio	1.06x	N/A
P/S Ratio	0.05x	1.33x
EV/Sales	0.26x	1.11x
EV/EBITDA	1.07x	0.00x
P/B Ratio	0.05x	16.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.18x	-5.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	0.25x	N/A
Forward P/S (NTM)	0.05x	N/A
Revenue & Growth
Revenue (TTM)	$258M	$7M
Revenue Growth (YoY)	-5.4%	52.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	69.9%	81.5%
Operating Margin (TTM)	14.0%	0.0%
EBITDA Margin (TTM)	24.5%	-58.0%
Net Margin (TTM)	4.7%	-55.6%
FCF Margin (TTM)	-3.6%	-19.3%
Net Income (TTM)	$12M	$-4M
FCF (TTM)	$-9M	$-1M
EPS (TTM)	$0.92	-$0.50
ROE (TTM)	5.0%	0.0%
ROA (TTM)	3.0%	-16123.0%
ROIC (TTM)	3.9%	0.0%
Financial Health
Cash	$15M	$2M
Debt	$70M	$343K
Net Cash/Debt	$-55M	$2M
Current Ratio (TTM)	2.16x	1.05x
Quick Ratio (TTM)	1.52x	0.68x
Debt/Equity (TTM)	0.28x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	1.94
52W Performance	49.2%	-16.5%
YTD Performance	185.3%	-55.7%
% from 52W High	-74.9%	-60.4%
% from 52W Low	88081.8%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.64x	2.90x
FCF Yield (TTM)	-74.5%	-14.5%
Earnings Yield (TTM)	96.0%	-41.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-9.0	33.4
EV/GP/RG	N/A	N/A
Ticker research	View EGRX research	View ZEOX research

Valuation

P/E Ratio

EGRX

1.06x

P/S Ratio

EGRX

0.05x

ZEOX

1.33x

EV/FCF

EGRX

-7.18x

ZEOX

-5.77x

Growth & revenue

Revenue Growth TTM

ZEOX

52.8%

EGRX

-5.4%

Forward Revenue Growth

EGRX

0.0%

ZEOX

0.0%

Profitability & performance

Gross Margin

ZEOX

81.5%

EGRX

69.9%

ROE

EGRX

5.0%

ZEOX

0.0%

FCF Yield %

ZEOX

-14.5%

EGRX

-74.5%

52-Week Performance

EGRX

49.2%

ZEOX

-16.5%

Detailed metrics comparison

EGRX

Eagle Pharmaceuticals Inc

ZEOX

ZEO ScientifiX Inc

Market Cap

EGRX$13M

ZEOX$9M

Enterprise Value

EGRX$67M

ZEOX$8M

Price

EGRX$0.97

ZEOX$1.19

P/E Ratio

EGRX1.06x

ZEOXN/A

P/S Ratio

EGRX0.05x

ZEOX1.33x

EV/Sales

EGRX0.26x

ZEOX1.11x

EV/EBITDA

EGRX1.07x

ZEOX0.00x

P/B Ratio

EGRX0.05x

ZEOX16.07x

P/FCF Ratio

EGRXN/A

ZEOXN/A

EV/FCF

EGRX-7.18x

ZEOX-5.77x

PEG Ratio

EGRXN/A

ZEOXN/A

Forward P/E (NTM)

EGRX0.25x

ZEOXN/A

Forward P/S (NTM)

EGRX0.05x

ZEOXN/A

Revenue (TTM)

EGRX$258M

ZEOX$7M

Revenue Growth (YoY)

EGRX-5.4%

ZEOX52.8%

Forward Rev Growth

EGRX0.0%

ZEOX0.0%

Gross Margin (TTM)

EGRX69.9%

ZEOX81.5%

Operating Margin (TTM)

EGRX14.0%

ZEOX0.0%

EBITDA Margin (TTM)

EGRX24.5%

ZEOX-58.0%

Net Margin (TTM)

EGRX4.7%

ZEOX-55.6%

FCF Margin (TTM)

EGRX-3.6%

ZEOX-19.3%

Net Income (TTM)

EGRX$12M

ZEOX$-4M

FCF (TTM)

EGRX$-9M

ZEOX$-1M

EPS (TTM)

EGRX$0.92

ZEOX-$0.50

ROE (TTM)

EGRX5.0%

ZEOX0.0%

ROA (TTM)

EGRX3.0%

ZEOX-16123.0%

ROIC (TTM)

EGRX3.9%

ZEOX0.0%

Cash

EGRX$15M

ZEOX$2M

Debt

EGRX$70M

ZEOX$343K

Net Cash/Debt

EGRX$-55M

ZEOX$2M

Current Ratio (TTM)

EGRX2.16x

ZEOX1.05x

Quick Ratio (TTM)

EGRX1.52x

ZEOX0.68x

Debt/Equity (TTM)

EGRX0.28x

ZEOX0.48x

Debt/Assets (TTM)

EGRX0.0%

ZEOX0.0%

Interest Coverage (TTM)

EGRXN/A

ZEOXN/A

Net Debt/EBITDA (TTM)

EGRX0.00x

ZEOX0.00x

Beta

EGRX0.88

ZEOX1.94

52W Performance

EGRX49.2%

ZEOX-16.5%

YTD Performance

EGRX185.3%

ZEOX-55.7%

% from 52W High

EGRX-74.9%

ZEOX-60.4%

% from 52W Low

EGRX88081.8%

ZEOX22.2%

Asset Turnover (TTM)

EGRX0.64x

ZEOX2.90x

FCF Yield (TTM)

EGRX-74.5%

ZEOX-14.5%

Earnings Yield (TTM)

EGRX96.0%

ZEOX-41.8%

Dividend Yield (TTM)

EGRXN/A

ZEOXN/A

Rule of 40

EGRX-9.0

ZEOX33.4

EV/GP/RG

EGRXN/A

ZEOXN/A

Ticker research

View EGRX research View ZEOX research

Metric	EGRX Eagle Pharmaceuticals Inc	ZEOX ZEO ScientifiX Inc
Market & Valuation
Market Cap	$13M	$9M
Enterprise Value	$67M	$8M
Price	$0.97	$1.19
P/E Ratio	1.06x	N/A
P/S Ratio	0.05x	1.33x
EV/Sales	0.26x	1.11x
EV/EBITDA	1.07x	0.00x
P/B Ratio	0.05x	16.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.18x	-5.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	0.25x	N/A
Forward P/S (NTM)	0.05x	N/A
Revenue & Growth
Revenue (TTM)	$258M	$7M
Revenue Growth (YoY)	-5.4%	52.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	69.9%	81.5%
Operating Margin (TTM)	14.0%	0.0%
EBITDA Margin (TTM)	24.5%	-58.0%
Net Margin (TTM)	4.7%	-55.6%
FCF Margin (TTM)	-3.6%	-19.3%
Net Income (TTM)	$12M	$-4M
FCF (TTM)	$-9M	$-1M
EPS (TTM)	$0.92	-$0.50
ROE (TTM)	5.0%	0.0%
ROA (TTM)	3.0%	-16123.0%
ROIC (TTM)	3.9%	0.0%
Financial Health
Cash	$15M	$2M
Debt	$70M	$343K
Net Cash/Debt	$-55M	$2M
Current Ratio (TTM)	2.16x	1.05x
Quick Ratio (TTM)	1.52x	0.68x
Debt/Equity (TTM)	0.28x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	1.94
52W Performance	49.2%	-16.5%
YTD Performance	185.3%	-55.7%
% from 52W High	-74.9%	-60.4%
% from 52W Low	88081.8%	22.2%
Efficiency & Yields
Asset Turnover (TTM)	0.64x	2.90x
FCF Yield (TTM)	-74.5%	-14.5%
Earnings Yield (TTM)	96.0%	-41.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-9.0	33.4
EV/GP/RG	N/A	N/A
Ticker research	View EGRX research	View ZEOX research